PANACEA BIOTEC LTD. - 531349 - I. Audited Financial Results (Standalone And Consolidated) For The Quarter / Financial Year Ended March 31, 2020 Ii. Passing Over Of Dividend For The Financial Year 2019-20
We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 29.06.2020, inter-alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter/ financial year ended March 31, 2020. The same were also reviewed by the Audit Committee in its meeting held on June 29, 2020. Further, we would like to confirm that the Auditors' Report on the Audited Financial Results (Standalone and Consolidated) for the financial Year ended March 31, 2020 is with unmodified opinion. Further, in view of losses, the Board of Directors has not recommended any dividend on the Preference as well as Equity Shares of the Company for the financial year ended March 31, 2020. The meeting of the Board of Directors commenced at 03:30 P.M. and concluded at 6:40 P.M.29-06-2020